Identification of BDRG cross-linked peptides. A, schematic describing the identification of BDRG cross-linked peptides by LC-MS3 analysis. Peptide A is cross-linked to peptide B by BDRG. The MS labile bond is indicated by the arrow. M is the ion corresponding to cross-linked peptide A-B. M1 and M2 are the product ions corresponding to peptide A and B, respectively, after MS2 fragmentation of cross-linked peptide A-B. m/z, mass to charge ratio; n, the integer number of charges on the analyte; H+, the mass of a proton = 1.007; MW, molecular weight of the analyte. B, example of MS data that led to the identification of an intermolecular cross-link in TFIIE. The detection of a 5+ peptide ion, M, with m/z of 849.26 in a high resolution Orbitrap MS1 scan triggers an MS2 scan event. During MS2, this ion is isolated and subjected to CID. This results primarily in fragmentation at the Rink bond, which liberates the two cross-linker-modified peptide ions, M1 and M2. Next, each product ion, M1 and M2, is isolated and subjected to CID to produce MS3 spectra that are used to identify its peptide sequence and the site of cross-linking by sequence database searching. The site of cross-linking is indicted by the Lys-468 residue. 468 corresponds to the mass in Daltons of the BD- or RG-modified lysine residue. The sum of the theoretical masses of the two identified cross-linker-modified peptides, M1 and M2, is calculated and compared with the measured mass of the precursor peptide, M.